| Literature DB >> 32510182 |
Tianyu F Qi1, Lei Guo1, Ming Huang1, Lin Li1, Weili Miao2, Yinsheng Wang1,2.
Abstract
Metastasis is the leading cause for mortality in melanoma patients. Here, an unbiased mass spectrometry-based quantitative proteomic method is utilized to assess differential protein expression in a matched pair of primary/metastatic melanoma cell lines (i.e., WM-115/WM-266-4) derived from the same patient. It is found that TBC1D7 is overexpressed in metastatic over primary melanoma cells, and elevated expression of TBC1D7 promotes the invasion of these melanoma cells in vitro, partly through modulating the activities of secreted matrix metalloproteinases 2 and 9. Additionally, interrogation of publicly available data show that higher mRNA expression of TBC1D7 predicts poorer survival in melanoma patients. Together, the results suggest TBC1D7 as a driver for melanoma cell invasion, which is an important element in melanoma metastasis. The proteomic data generated from this study may also be useful for exploring the roles of other proteins in melanoma metastasis.Entities:
Keywords: SILAC; TBC domain-containing proteins; TBC1D7; mass spectrometry; melanoma metastasis; quantitative proteomics
Mesh:
Substances:
Year: 2020 PMID: 32510182 PMCID: PMC9362880 DOI: 10.1002/pmic.201900347
Source DB: PubMed Journal: Proteomics ISSN: 1615-9853 Impact factor: 5.393